Single-cell Omics Market Synopsis

Single-cell Omics Market Size is Valued at USD 2.56 Billion in 2023, and is Projected to Reach USD 16.64 Billion by 2032, Growing at a CAGR of 23.12% From 2024-2032.

Single cell omics business is a rapidly growing branch of biotechnology, which involves the study of molecular traits of single cells rather than groups and aggregates of cells. ScRNA-seq and other technologies such as scDNA-Seq and single-cell proteomics fall under this market, allowing researchers to dissect the cellular heterogeneity within tissues and analyze cellular function, differentiation, and disease pathology at immense detail. These single-cell omics secretes important information for recognizing many diseases at molecular levels for personalized treatments, drug discovery, which in turn contributes massive growth and innovation in the field of biotechnology and pharmaceutical industries.

• The single-cell omics market is also on the rise since new technologies appear that let researchers study individual cells in great detail. This market includes high-throughput technologies, encompassing single-cell genomics, transcriptomics, proteomics, metabolomics, and more giving a view of cell functioning and variation. As the trend of individualized medicine and precision approaches advances, single-cell omics helps to investigate the bio-complexity and contribute to a better understanding of diseases, biomarkers identification, treatment planning, and drug design.
• Critically driving forces influencing the market are the rise in the cases of chronic illness, technological improvement in sequencing techniques, and the augment in funds for research activities. Also, the era of applying artificial intelligence and machine learning for analyzing large data sets produced in single cell omics is improving the experiences of investigators and medical care providers. Nonetheless, some of the constraints include; high costs relating to implementation of advanced technologies, data intensity and the need for professional staff may act as a limiting factor to market growth.
• North America has been identified to have a sizable market in single-cell omics due to the biotechnology companies, research institutions. On the other hand, certain regions are likely to have higher growth over the forecast period with Asia Pacific having higher market growth because of growing research activity, expansion of healthcare industry and increasing funding on life science research. In general, the growth of the single-cell omics market seems promising in the future as the methods improve and cell heterogeneity becomes essential for understanding health and disease.

Single-cell Omics Market Trend Analysis

Advancements Driven by Personalized Medicine

• The increasing need for targeted therapies keep the researchers on toes where they continue to use single-cell analysis to understand the diverse diseases down at the cellular level. This trend is more pronounced in cancer research, immunology and neuroscience. In the context of oncology, it is crucial to develop specific treatments taking into account the microenvironments of tumor tissues as well as tumor heterogeneity; in immunology, the immune response has to be analyzed at the single cell level to design specific immunotherapies. Likewise, in neurobiology precise analysis of the ability of neural cells to interact can facilitate the understanding of neurological disorders and the subsequent development of more appropriate treatment strategies. This drive towards the higher level of individualization in treatment, targeting gene expression at a single cell level, engulfs the fields of applied single cell methodologies and the improved diagnostic and therapeutic approaches.
• Due to the ever reducing costs of single-cell sequencing technologies and the increasing availability for different laboratories, research institutions are gradually adopting these complex technologies. Such a wide range of fields is not only enlarging the utilization of single-cell analysis but also making advanced mechanisms more accessible for in-depth research in various sciences. In addition, new developments in the fields of data analysis and bioinformatics are improving the understanding of single-cell data, allowing researchers to get a great deal out of their data. Collectively these are driving very high market growth in the single-cell omics industry that is set to become a cornerstone for development of personalized medicine and targeted therapies.

Transforming the Single-Cell Omics Market

• Integration of multi-omics at the single cell level is progressively revolutionizing the single-cell omics market through Genomics, transcriptomics, proteomics, and metabolomics. These integrative methods enable the analysts to capture global pictures of cellular functions and be states, which gives the viewer a further perceptive of the cellular functions and states than that which can be seen from other most common bulk analysis techniques. Each piece of data contains information at different levels of organization and thus combining many layers of information helps scientists get a clearer understanding of the relations and regulation within single cells, which in turn may provide a vital clue to understanding of various biological processes and pathologies.
• New developments in analytical software and bioinformatics are also improving the analysis of single-cell omics data and broadening the ability of researchers to make conclusions and draw implications from the data. This is especially so given that the volume and comprehensiveness of the single-cell data sets are rapidly growing and require enhanced analysis abilities to discern useful information patterns. This is especially so because the volume and comprehensiveness of the single-cell data are rapidly growing, and it is challenging to extract use-ful patterns from such data. However, increasing academic-industry partnership coupled with researchers with single-cell omics and biotechnology firms coupled with pharmaceutical companies is pushing the market growth and broadening the usage of single cell omics for various uses. These collaborations are opening opportunities for new and innovative sources and therapies that present the foundation for big scientific advances in biology and targeted medication.

Single-cell Omics Market Segment Analysis:

Single-cell Omics Market Segmented based on By Product Type, By Application and By End-User

By Product Type, Single-Cell Genomics segment is expected to dominate the market during the forecast period

• Single cell genomics is a revolutionary technique that offers an opportunity to assess genomic material at cellular level and, therefore, to uncover cellular and evolutionary variations. This technology is specifically useful in cancer research where investigation of small populations of cancer cells or genes involving tumor formation is possible. Because multiple cells are often taken from a patient and individual samples can be analyzed for DNA, scientists are able to identify genetic differences which potentially may be associated with tumor heterogeneity and new mutations that drive specific cancer types. This fine-grained map of genomic variation is crucial for dissecting the mechanisms that underlie cancer, and opens the door to targeting therapies and carrying out individualized treatment.
• The need to combine various treatments that are used in treatment centres is essential in the single-cell genomics market, given that consumers are demanding treatments they can receive based on their profile. Due to ongoing technological development, raw projects and secondary analysis costs decrease, encouraging the translation of single-cell genomics into practice. All of the aforementioned technologies enable a higher definition of genetic predispositions affecting patients’ outcomes to certain medications and setting the stage for personalized therapy. Therefore, the adoption of single-cell genomics in the study of cancer and the development of intervention strategies should increase our understanding of tumour biology and develop the diagnosis and treatment process.

By End-User, Pharmaceutical & Biotechnology  segment held the largest share in 2023

• The companies in the pharmaceutical and biotechnology sectors are the key drivers in operations of single cell analysis technologies that affect their research and development hugely. These organizatiоns leverage single-cell data to improve outcomes of drug-based interventions, while allowing orgаnizations to cоntinuely integrate and dnе scrutable advances in understanding disease states with single-cell sensitivity and depth. Although single cell analysis is not completely clear whether such responses are achieving a therapeutic effect or creating resistance, by focusing on the peculiarities of the individual cells, the corporations can obtain rich information about how the cells respond to certain treatment regimens and the potential failures in the pipeline. This capability is particularly important in developing therapies that would directly address the needs of a given patient allowing for the enhancement of outcomes and reduction of risks associated with treatment programs.
• This growing focus on precision medicine and the related novel therapeutic approaches has accelerated investment in single cell technologies in pharmaceutical and biotechnology industries. Since these firms operate in a dynamic environment of biopharmaceutical companies, such a tool to create a targeted treatment based on the individual content of cells is a advantage. Furthermore, the use of single-cell methods enable the optimization of clinical trial even at the patient population level because patient populations can be trimmed at the single cell level before trials, something that makes drug trials more accurate and faster in terms of reaching the market. Therefore, it can be concluded that practical application of single-cell analysis within the R&D strategies of the pharmaceutical and biotechnology corporations will be able to support a critical shift in the strategy of drug development and the approach to healthcare delivery in the near future.

Single-cell Omics Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America Single-Cell Omics Market is primarily dominated by the United States due to the enhanced biopharmaceutical business and various research institutes. The rising incidence rates of chronic illnesses such as cancers, diabetes, and hereditary diseases have also made single-cell analysis more popular with researchers due to increased needs to understand the multifactorial biology of the diseases. To address this urgency, there are favorable industry drivers such as availability of leading market players who undertake immense commitment on research and innovation. In addition, endogenous government policies, as well as existed or newly established funding schemes, enhance these endeavors and help to progress single-cell biology and relevant techniques.
• Single-cell omics has emerged as a promising field in healthcare now, especially in North America because the current trend of moving to personalized medicine is quite influential on its utilization. Such uses of these machine learning technologies are improving clinical diagnostics and precision of treatment techniques and favours patient benefits. This broad application of single-cell analysis and their understanding by the healthcare providers about its distinctive suitability for individual patient’s profile makes market experience timely expansion and innovation. Furthermore, increased co-investment by academic organizations and industry players will foster the generation of new techniques and applications to grow the North American market and establish a position as a global single-cell omics leader.

Active Key Players in the Single-cell Omics Market

• Danaher Corporation
• CYTENA GmbH
• 10x Genomics
• BD
• CELLENION
• PerkinElmer Inc.
• ANGLE plc
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Mission Bio
• Standard BioTools Inc.
• Other Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Single-cell Omics Market by Product Type
 4.1 Single-cell Omics Market Snapshot and Growth Engine
 4.2 Single-cell Omics Market Overview
 4.3 Cell Genomics
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Cell Genomics: Geographic Segmentation Analysis
 4.4 Single-Cell Transcriptomics
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Single-Cell Transcriptomics: Geographic Segmentation Analysis
 4.5 Single-Cell Proteomics
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Single-Cell Proteomics: Geographic Segmentation Analysis
 4.6 Single-Cell Metabolomics
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Single-Cell Metabolomics: Geographic Segmentation Analysis

Chapter 5: Single-cell Omics Market by Application
 5.1 Single-cell Omics Market Snapshot and Growth Engine
 5.2 Single-cell Omics Market Overview
 5.3 Oncology
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Oncology: Geographic Segmentation Analysis
 5.4 Cell Biology
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Cell Biology: Geographic Segmentation Analysis
 5.5 Neurology
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Neurology: Geographic Segmentation Analysis
 5.6 Immunology
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Immunology: Geographic Segmentation Analysis

Chapter 6: Single-cell Omics Market by End-User
 6.1 Single-cell Omics Market Snapshot and Growth Engine
 6.2 Single-cell Omics Market Overview
 6.3 Pharmaceutical & Biotechnology Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Pharmaceutical & Biotechnology Companies: Geographic Segmentation Analysis
 6.4 Academic and Research Organizations
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Academic and Research Organizations: Geographic Segmentation Analysis
 6.5 Hospital and Diagnostic Laboratories
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Hospital and Diagnostic Laboratories: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Single-cell Omics Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 CYTENA GMBH
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 10X GENOMICS
 7.4 BD
 7.5 CELLENION
 7.6 PERKINELMER INC
 7.7 ANGLE PLC
 7.8 ILLUMINA INC
 7.9 BIO-RAD LABORATORIES INC
 7.10 MISSION BIO
 7.11 STANDARD BIOTOOLS INC
 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global Single-cell Omics Market By Region
 8.1 Overview
 8.2. North America Single-cell Omics Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product Type
  8.2.4.1 Cell Genomics
  8.2.4.2 Single-Cell Transcriptomics
  8.2.4.3 Single-Cell Proteomics
  8.2.4.4 Single-Cell Metabolomics
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Oncology
  8.2.5.2 Cell Biology
  8.2.5.3 Neurology
  8.2.5.4 Immunology
  8.2.6 Historic and Forecasted Market Size By End-User
  8.2.6.1 Pharmaceutical & Biotechnology Companies
  8.2.6.2 Academic and Research Organizations
  8.2.6.3 Hospital and Diagnostic Laboratories
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Single-cell Omics Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product Type
  8.3.4.1 Cell Genomics
  8.3.4.2 Single-Cell Transcriptomics
  8.3.4.3 Single-Cell Proteomics
  8.3.4.4 Single-Cell Metabolomics
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Oncology
  8.3.5.2 Cell Biology
  8.3.5.3 Neurology
  8.3.5.4 Immunology
  8.3.6 Historic and Forecasted Market Size By End-User
  8.3.6.1 Pharmaceutical & Biotechnology Companies
  8.3.6.2 Academic and Research Organizations
  8.3.6.3 Hospital and Diagnostic Laboratories
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Single-cell Omics Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product Type
  8.4.4.1 Cell Genomics
  8.4.4.2 Single-Cell Transcriptomics
  8.4.4.3 Single-Cell Proteomics
  8.4.4.4 Single-Cell Metabolomics
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Oncology
  8.4.5.2 Cell Biology
  8.4.5.3 Neurology
  8.4.5.4 Immunology
  8.4.6 Historic and Forecasted Market Size By End-User
  8.4.6.1 Pharmaceutical & Biotechnology Companies
  8.4.6.2 Academic and Research Organizations
  8.4.6.3 Hospital and Diagnostic Laboratories
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Single-cell Omics Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product Type
  8.5.4.1 Cell Genomics
  8.5.4.2 Single-Cell Transcriptomics
  8.5.4.3 Single-Cell Proteomics
  8.5.4.4 Single-Cell Metabolomics
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Oncology
  8.5.5.2 Cell Biology
  8.5.5.3 Neurology
  8.5.5.4 Immunology
  8.5.6 Historic and Forecasted Market Size By End-User
  8.5.6.1 Pharmaceutical & Biotechnology Companies
  8.5.6.2 Academic and Research Organizations
  8.5.6.3 Hospital and Diagnostic Laboratories
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Single-cell Omics Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product Type
  8.6.4.1 Cell Genomics
  8.6.4.2 Single-Cell Transcriptomics
  8.6.4.3 Single-Cell Proteomics
  8.6.4.4 Single-Cell Metabolomics
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Oncology
  8.6.5.2 Cell Biology
  8.6.5.3 Neurology
  8.6.5.4 Immunology
  8.6.6 Historic and Forecasted Market Size By End-User
  8.6.6.1 Pharmaceutical & Biotechnology Companies
  8.6.6.2 Academic and Research Organizations
  8.6.6.3 Hospital and Diagnostic Laboratories
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Single-cell Omics Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product Type
  8.7.4.1 Cell Genomics
  8.7.4.2 Single-Cell Transcriptomics
  8.7.4.3 Single-Cell Proteomics
  8.7.4.4 Single-Cell Metabolomics
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Oncology
  8.7.5.2 Cell Biology
  8.7.5.3 Neurology
  8.7.5.4 Immunology
  8.7.6 Historic and Forecasted Market Size By End-User
  8.7.6.1 Pharmaceutical & Biotechnology Companies
  8.7.6.2 Academic and Research Organizations
  8.7.6.3 Hospital and Diagnostic Laboratories
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research